📰 Financial Code News
Page 10 - Financial Code News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Financial Code. Real-time updates on events, politics, business and more.
October 18, 2023
EQS-News: ABIVAX / Key word(s): IPO Abivax announces the filing of an amended registration statement, including an estimated...
October 16, 2023
EQS-News: ABIVAX / Key word(s): IPOAbivax announces the start of the roadshow for its proposed global offering and proposed Nasdaq listing 16.10.2023 / 17:40 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax announces the start of the roadshow for its proposed global offering and p...
October 16, 2023
PARIS, FRANCE / ACCESSWIRE / October 16, 2023 / Abivax SA (PARIS:FR) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's
October 16, 2023
EQS-News: ABIVAX / Key word: IPO Abivax announces the start of the roadshow for its proposed global offering and proposed Nasdaq listing 16.10.2023 / 17:40...
October 13, 2023
SOCIÉTÉ GÉNÉRALE SCF 20,000,000,000 Euro Medium Term Note Programme for the issue of Obligations Foncières ...
October 12, 2023
While federal and state laws have long prohibited providers of financial services from engaging in unfair, deceptive, and abusive acts and practices (“UDAAP”), such prohibitions...
October 5, 2023
In Short - The Situation: France has had a registration and licensing process for digital assets service providers for over three years. The recent crisis with Terra Luna...
October 2, 2023
This press release must not be distributed directly or indirectly in the United States, Canada, Australia, or Japan. ...
October 2, 2023
02.10.2023 - Regulatory News: This press release must not be distributed directly or indirectly in the United States, Canada, Australia, or Japan. Advicenne (Euronext Growth - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and ...
September 29, 2023
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION FOR THE FIRST HALF OF 2023 AND THE KEY EVENTS OF THE PERIOD Clinical development strategy based on two platforms: the...